A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle- β0 Thalassemia)
Condition: Sickle Cell Disease Intervention: Drug: IMR-687 Sponsor: Imara, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials